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The aim of this study was to review two cases of ruptured
hepatoblastoma treated with primary surgical resection.
Hepatoblastoma is the most common primary liver
malignancy of childhood, although it remains infrequent.
A rare, but serious condition is when the tumor presents
with spontaneous rupture. This is a well-known phenomenon;
however, it is rarely reported in the literature, and the
long-term outcomes of various management strategies are
currently unclear. We present two cases of patients in
whom primary surgical resection was performed and discuss
outcomes, and also present a current literature review.
Children with ruptured hepatoblastoma treated with
emergency primary surgical resection, followed by adjuvant
chemotherapy, may have favorable outcomes. Ann Pediatr
Surg 10:54–56 c 2014 Annals of Pediatric Surgery.
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Introduction
Hepatoblastoma is the most common primary liver
malignancy of childhood, and accounts for B80% of liver
tumors in children [1]. The incidence of hepatoblastoma
has almost doubled since the 1970s, although it remains
rare, with an estimated 1.5 cases per million children [2].
With recent advances in chemotherapy protocols and
surgical resection techniques, survival rates approach
100% for stage 1 tumors [1]. It is universally agreed upon
that the most important prognostic factor is to achieve
complete resection without residual disease [3]. Those
tumors that are deemed inoperable after neoadjuvant
chemotherapy because of large tumor size, including
involvement of all four sectors of the liver; location,
including near or involving the portal veins, or all three
hepatic veins; or tumors that are multifocal should be
treated by liver transplantation [1,4].
A rare but serious situation is when the tumor presents
with spontaneous rupture or hemorrhage, which has
historically had a poor prognosis [5]. Although presentation
of ruptured hepatoblastoma is a well-known phenomenon,
it is rarely reported in the literature. To date, 10 cases of
ruptured hepatoblastoma have been reported in the
literature that discuss treatment and outcomes, each
utilizing various treatment strategies [1,5–8]. There are
several other articles that report cases of ruptured
hepatoblastoma as part of larger cohorts of patients;
however, these cases are not discussed in detail and there
is no mention of treatment strategies or outcomes.
Currently, there is no consensus on which management
strategy is superior or offers the most favorable long-term
outcome, and the question remains as to whether a
ruptured tumor should be considered primarily resectable.
We present two cases of ruptured hepatoblastoma that
were managed with primary hepatectomy, followed by
adjuvant chemotherapy, and discuss therapeutic options.
Case reports
Case 1
A 10-year-old female presented to the emergency
department complaining of abdominal pain and multiple
episodes of syncope, with a hematocrit of 23. A computed
tomographic (CT) scan indicated a large amount of blood
in the abdomen, as well as a large tumor arising from
the left lobe of the liver. She was taken emergently to the
operating room, where a large amount of blood and clot
were observed in the abdomen, along with active
bleeding from a necrotic tumor in segment II of the
liver. The tumor was fungating in appearance and had
satellite lesions just proximal to it, extending a centi-
meter into segment III (PRETEXT stage 1 by CT) [9].
A frozen section was sent intraoperatively, which returned
showing a malignant tumor that favored the diagnosis
of hepatoblastoma. There was no gross evidence of
metastatic disease or peritoneal studding. A left lateral
segmentectomy, removing segment II and part of
segment III, was performed using an Endo-GIA (Covidien,
Mansfield, Massachusetts, USA) stapler, resecting beyond
the satellite lesions. Negative histological margins were
achieved, and histology was mixed fetal and embryonal
types. The remaining part of the left lobe of the liver,
including segment IV, as well as the rest of the liver
appeared normal. The patient’s postlaparotomy alpha-
fetoprotein level was greater than 75 000. Following
resection, the patient was treated with adjuvant che-
motherapy, and was free of disease, by imaging, for over 1
year, before she developed recurrence in the remaining
portion of the liver (PRETEXT stage 4 lesion) [9]. There
was no evidence of extra-hepatic disease at the time of
recurrence. The patient then underwent additional che-
motherapy, followed by orthotopic liver transplant second-
ary to the unresectability of the recurrent liver lesion.
Approximately 1 year after her liver transplant, she
developed distant metastatic disease, including abdominal,
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lung, and brain metastasis, and was treated with comfort
measures only secondary to the extensive metastases. The
patient subsequently died 3 years after her initial
presentation.
Case 2
A 3-year-old female, with a new liver mass, considered likely
to be PRETEXT stage 1 hepatoblastoma because of the
markedly elevated alpha-fetoprotein levels and appearance
on CT scan, presented to the emergency department with
acute onset of severe abdominal pain 3 days before elective
liver resection that was to be followed by adjuvant
chemotherapy. There was no traumatic inciting event, and
a repeat CT scan of the abdomen showed free intraper-
itoneal fluid consistent with blood and evidence of a
ruptured tumor in the right lobe of the liver. The patient
was then taken to the operating room, where a bleeding
tumor was noted on the right side of the liter. Intraoperative
frozen section confirmed hepatoblastoma. A segment V/VI
resection was performed with over 1 cm negative margins
and without evidence of lymphovascular invasion. The final
pathology returned a tumor with mixed fetal and embryonal
histology. She was treated with adjuvant chemotherapy on
the basis of the standard COG regimens and remains disease
free greater than 4 years after resection.
Discussion
Rupture is a rare, but serious presentation of hepato-
blastoma, and has historically been considered to be
associated with a poor prognosis [5,8]. This is based
primarily on the high mortality rates reported in adult
populations with ruptured hepatocellular carcinoma, with
subsequent diffuse peritoneal disease and metastases
[10]. In children, PRETEXT staging plays a central role
in deciding therapy [9]. However, our cases indicate that
ruptured hepatoblastoma in children may not have the
same poor outcomes on the basis of our experience and
the literature. Although the presentation of ruptured
hepatoblastoma is mentioned in most basic surgical
textbooks, the discussion of the presentation, treatment,
and outcomes is minimal. It is unclear as to how many
patients will develop diffuse peritoneal implants [7] or
abdominal relapse following rupture in children and
whether therapies such as total abdominal radiation
should be considered for these cases [1].
Of the 10 cases of ruptured hepatoblastoma that have
been reported in the literature, multiple methods of
treatments utilizing surgical intervention are described,
with the main difference being the timing of surgical
resection (Table 1) [5,11–13]. Of the reported cases, no
one management strategy was noted to be superior; some
urgent intervention is obviously necessary. Primary
hepatectomy, followed by chemotherapy in stable
patients appears to be a reasonable choice in favorable
cases with resectable disease, with the additional
advantage of rapid control of bleeding and histologic
diagnosis. In our cases, we were also able to achieve
complete resection. In cases where complete microscopic
resection may not be achieved, the child may still have
favorable chances for survival as evidenced by the results
in the SIOPEL-1 trial, where 11 patients with positive
microscopic margins had no local recurrence following
neoadjuvant chemotherapy [4]. The preoperative CT
scan is crucial in determining the resectability of the
lesion by PRETEXT staging and may help in deciding on
the therapy.
The question that remains is as follows: should children who
present with ruptured hepatoblastoma with favorable staging
undergo primary surgical resection, followed by chemother-
apy, or should a temporizing procedure be performed to
allow for treatment with neoadjuvant chemotherapy before
definitive surgical resection? Transarterial embolization
(TAE) is a good temporizing alternative as it is minimally
invasive and can control the bleeding to allow for a complete
workup and neoadjuvant chemotherapy for nonresectable
lesions. The downsides to percutaneous TAE are that it is
technically difficult in children secondary to the size of the
vessels, and it may also lead to complications delineating
anatomy and blood supply in future hepatic resection, as
well as interfere with the delivery of directed chemotherapy
to the tumor site [10]. In addition, this procedure may not
be available in all centers as not every center has the
expertise required to perform this procedure.
Our two cases presented here add to the growing body
of evidence that pediatric patients who present with
ruptured hepatoblastoma can have successful outcomes
with emergent hepatectomy, followed by adjuvant
chemotherapy. Unquestionably, the best outcomes are
achieved with early diagnosis and surgical intervention,
followed by adjuvant chemotherapy, as patients in whom
an urgent procedure and chemotherapy were not
performed and administered had a poor prognosis. Initial
stabilization with TAE may be successful if readily
available and the patient is stable; however, this is often
technically difficult in young children and the risk of
rebleeding is unknown. This report is limited because of
the fact that we only present two cases that are both
PRETEXT 1 cases favorable for resection. No definitive
conclusions are possible; however, our cases add to the
scarce literature on this subject.
Further study should focus on determining the frequency
of peritoneal seeding following tumor rupture, the effects
Table 1 All reported cases of ruptured hepatoblastoma and
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chemotherapy [5,8]
2 Disease free for 2 + years
Emergent resection without
adjuvant chemotherapy [11]
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1 Died during initial admission
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on tumor recurrence, and whether other modalities of
treatment, including the use of total abdominal radiation
therapy, would aid in survival. In addition, patient
characteristics affecting morbidity and mortality following
ruptured hepatoblastoma should be examined. Because of
the paucity of cases of ruptured hepatoblastoma reported
in the literature, each report of treatment and outcomes
is beneficial to the practicing surgeon who may encounter
this rare presentation in practice.
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